drugset / Trial / NCT00999791

Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema

NCT00999791

Parallel-groupTreatment

Summary

Diffuse Macular Edema is the main cause of visual disorders in diabetic patients. Diclofenac is a cheap drug available in most of treatment centers.in animal studies the safe dosage is identified that can be used in diffuse diabetic macular edema for treatment. in this study, we are going to compare the effect of intra vitreal injection of Diclofenac and Bevacizumab in primary treatment of diffuse diabetic macular edema.

Timeline

Start
2009-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bevacizumab Monoclonal antibody Intravitreal
Comparator Diclofenac Other / unclassified Intravitreal